1762 — Chunghwa Chemical Synthesis & Biotech Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapNeutral

Market Cap
TWD1.86bn
Enterprise Value
TWD2.50bn
Revenue
TWD1.35bn

Annual balance sheet for Chunghwa Chemical Synthesis & Biotech Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	149	195	301	270	222
Net Total Accounts Receivable
Net Total Receivables	368	396	312	257	208
Total Inventory
Prepaid Expenses
Total Current Assets	1,002	1,357	1,449	1,788	1,441
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,542	1,868	1,964	2,292	2,199
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	3,147	4,381	4,564	5,172	4,763
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	400	635	614	831	425
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	649	1,487	1,371	1,821	1,406
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	2,498	2,894	3,193	3,350	3,357
Total Liabilities & Shareholders' Equity	3,147	4,381	4,564	5,172	4,763
Total Common Shares Outstanding